Cmed shows encapsia® at DIA 2017

Written by Cmed

Cmed, an innovative, technology-led oncology CRO, today announced its participation at the DIA Annual Meeting in Chicago, Illinois (June 19-21), where it will show how encapsia® enables faster clinical trial delivery, increased patient safety and better decision making with its’ live, actionable data Insights (Booth 1359).

Cmed has considerable expertise in the delivery of complex and demanding clinical trials, including early phase, Proof of Concept, oncology, rare diseases and adaptive studies. Cmed couples this experience with encapsia®, a proven new generation clinical data suite already used to successfully complete studies for both large and small Biopharma companies, to set up and conduct trials faster, smarter and more efficiently. This unique combination of operational expertise and the latest technology, supported by optimized processes, allows Sponsors to collect, query, clean, visualize and analyze their clinical trial data in ways that were not possible before.

Cmed will demonstrate how immediate access to real-time clinical data can support effective and efficient decision making, improve patient safety, increase productivity and drive data quality while reducing costs and timelines, at Booth 1359. Attendees will also be able to find out about Cmed’s full suite of services, which ranges from full service to stand-alone solutions and functional services.

To schedule a meeting with the Cmed team during DIA 2017, contact Patrick Maloney, Director of Business Development at pmaloney@cmedresearch.com, or Jessi Lanuza, Associate Director of Business Development at jlanuza@cmedresearch.com.